If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions.

The Food and Drug Administration (FDA) has authorized the marketing of the Dexcom G6 integrated continuous glucose monitoring (iCGM) system for determining glucose levels in patients aged ≥2 ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the U ...

DexCom, Inc., the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the publication and presentation of two new studies during the 14 th ...

In a 2-pronged move, the FDA approved the sale of the Dexcom G6 integrated continuous glucose monitoring system for determining blood glucose levels and also classified the unit as a class II ...

Dexcom provides more choice to users by launching Spanish-language capabilities for its mobile app for the best-selling real-time CGM in the world Spanish-speaking patients can opt to use the ...

Revolutionary new Continuous Glucose Monitoring System eliminates fingersticks* for people with diabetes VANCOUVER, Sept. 9, 2019 /CNW/ - DexCom Inc. (NASDAQ:DXCM), a leader in continuous glucose ...

Dexcom, Inc., a global leader in real-time continuous glucose monitoring, is happy to share that people with type 1 diabetes who are 25 years of age or under may now be eligible for provincial ...

† If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. * For a list of compatible devices ...

February 6th, 2014 Medgadget Editors Medicine, Pediatrics Dexcom won FDA approval to offer its G4 Platinum continuous glucose monitor for use by kids as young as two years.